{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:22:16Z","timestamp":1790090536944,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825575"],"award-info":[{"award-number":["825575"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Rare diseases present critical challenges to healthcare systems, patients, and caregivers due to their low prevalence and unique characteristics. Designing clinical trials and developing statistical methodologies for evaluating interventions in rare diseases face several challenges. The \u201cEBStatMax\u201d project, part of the European Joint Programme on Rare Diseases\u2019 Demonstration Projects, aimed to address one of these challenges, namely: designing and analyzing longitudinal cross-over data in rare diseases, like Epidermolysis bullosa simplex (EBS). Although the main findings of the project have been published elsewhere, this manuscript reflects on additional hurdles encountered during the project, particularly regarding outcomes and methodological considerations. It explores issues surrounding outcome measurement, statistical methodology, and clinical considerations, emphasizing their broader relevance to methodological advancements in rare disease research beyond this specific case. This manuscript highlights the critical role of international collaboration in rare disease research to enhance evidence quality and aims to inspire further advancements in the field.<\/jats:p>","DOI":"10.1186\/s13023-025-03805-1","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:21:30Z","timestamp":1749108090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reflection on clinical and methodological issues in rare disease clinical trials."],"prefix":"10.1186","volume":"20","author":[{"given":"Johan","family":"Verbeeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Geroldinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin E.","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne C.","family":"Bathke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Molenberghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Laimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"3805_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, et al. Estimating cumulative point prevalence of rare diseases: analysis of the orphanet database. Eur J Hum Genet. 2020;28:165\u201373. https:\/\/doi.org\/10.1038\/s41431-019-0508-0.","journal-title":"Eur J Hum Genet."},{"key":"3805_CR2","unstructured":"Orphanet. Orphanet reports series \/ procedures 2023. https:\/\/www.orpha.net\/consor\/cgi-bin\/Education_Home.php?lng=EN. Accessed: 2023-08-30."},{"key":"3805_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13023-021-02061-3","volume":"16","author":"A Tisdale","year":"2021","unstructured":"Tisdale A, Cutillo C, Nathan R, et al. The ideas initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems. Orphanet J Rare Dis. 2021;16:429. https:\/\/doi.org\/10.1186\/s13023-021-02061-3.","journal-title":"Orphanet J Rare Dis"},{"key":"3805_CR4","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.3390\/ijerph19138208","volume":"19","author":"C Valc\u00e1rcel-Nazco","year":"2022","unstructured":"Valc\u00e1rcel-Nazco C, et al. Health-related quality of life and perceived burden of informal caregivers of patients with rare diseases in selected european countries. Int J Environ Res Public Health. 2022;19:8208. https:\/\/doi.org\/10.3390\/ijerph19138208.","journal-title":"Int J Environ Res Public Health"},{"key":"3805_CR5","unstructured":"ASTERIX: advances in small trials design for regulatory innovation and excellence 2013. https:\/\/www.asterix-fp7.eu\/. FP7-HEALTH-2013-INNOVATION-1 Grant-Agreement No. 603160. Accessed: 2023-08-30."},{"key":"3805_CR6","unstructured":"IDEAL: integrated design and analysis of small population group trials 2013. https:\/\/www.ideal.rwth-aachen.de\/. EU grant agreement no. 602552. Accessed: 2023-08-30."},{"key":"3805_CR7","unstructured":"INSPIRE: innovative methodology for small populations research 2013. https:\/\/warwick.ac.uk\/fac\/sci\/med\/research\/hscience\/stats\/completedprojects\/inspire\/. EU grant agreement no. 602144. Accessed: 2023-08-30."},{"key":"3805_CR8","unstructured":"European Joint Programme on Rare Diseases. Internal call for proposals 2019 - clinical trials methodology demonstration projects 2019. https:\/\/www.ejprarediseases.org\/funded-projects-demonstration\/. EU grant agreement no. 825575. Accessed: 2023-08-30."},{"key":"3805_CR9","unstructured":"EBStatMax 2023. https:\/\/www.ejprarediseases.org\/funded-projects-demonstration. EBStatMax: State-of-the-art statistical design and analysis for maximal success with minimal patient burden in Epidermolysis bullosa trials, H2020 Societal Challenges, Grant agreement no. 825575. Accessed: 2023-08-30."},{"key":"3805_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaad.2018.01.019","volume":"78","author":"V Wally","year":"2018","unstructured":"Wally V, et al. Diacerein orphan drug development for epidermolysis bullosa simplex: a phase 2\/3 randomized, placebo-controlled, double-blind clinical trial. J Am Acad Dermatol. 2018;78:892\u2013901.","journal-title":"J Am Acad Dermatol"},{"key":"3805_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183:614\u201327.","journal-title":"Br J Dermatol"},{"key":"3805_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/biom.13920","volume":"79","author":"J Verbeeck","year":"2023","unstructured":"Verbeeck J, et al. How to analyze continuous and discrete repeated measures in small sample cross-over trials? Biometrics. 2023;79:1\u201315.","journal-title":"Biometrics"},{"issue":"1","key":"3805_CR13","doi-asserted-by":"publisher","first-page":"e2200236","DOI":"10.1002\/bimj.202200236","volume":"66","author":"M Geroldinger","year":"2024","unstructured":"Geroldinger M, Verbeeck J, Thiel KE, Molenberghs G, Bathke AC, Laimer M, Zimmermann G. A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases. Biometr J. 2024;66(1):e2200236. https:\/\/doi.org\/10.1002\/bimj.202200236.","journal-title":"Biometr J"},{"key":"3805_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13023-023-02990-1","volume":"18","author":"M Geroldinger","year":"2023","unstructured":"Geroldinger M, et al. Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials. Orphanet J Rare Dis. 2023;18:391.","journal-title":"Orphanet J Rare Dis"},{"key":"3805_CR15","doi-asserted-by":"publisher","first-page":"108015","DOI":"10.1016\/j.csda.2024.108015","volume":"199","author":"J Nyberg","year":"2024","unstructured":"Nyberg J, Hooker AC, Zimmermann G, Verbeeck J, Geroldinger M, Thiel KE, Molenberghs G, Laimer M, Wally V. Optimizing designs in clinical trials with an application in treatment of Epidermolysis bullosa simplex, a rare genetic skin disease. Comput Stat Data Anal. 2024;199:108015. https:\/\/doi.org\/10.1016\/j.csda.2024.108015.","journal-title":"Comput Stat Data Anal"},{"key":"3805_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13023-023-02819-x","volume":"18","author":"J Verbeeck","year":"2023","unstructured":"Verbeeck J, et al. Composite endpoints, including patient reported outcomes, in rare diseases. Orphanet J Rare Dis. 2023;18:262.","journal-title":"Orphanet J Rare Dis"},{"key":"3805_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.sjpain.2016.06.012","volume":"13","author":"G Heller","year":"2016","unstructured":"Heller G, Manuguerra M, Chow R. How to analyze the visual analogue scale: myths, truths and clinical relevance. Scand J Pain. 2016;13:67\u201375.","journal-title":"Scand J Pain"},{"key":"3805_CR18","first-page":"182","volume":"4","author":"D Noback","year":"2015","unstructured":"Noback D, ad Cuellar PC, Lombardi J, Swart E, Rosenwasser M. Evaluating pain in orthopedic patients: can the visual analog scale be used as a long-term outcome instrument? J Pain Relief. 2015;4:182.","journal-title":"J Pain Relief"},{"key":"3805_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1526-5900(03)00716-8","volume":"4","author":"MP Jensen","year":"2003","unstructured":"Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003;4:407\u201314.","journal-title":"J Pain"},{"key":"3805_CR20","unstructured":"Food and Drug Administration (FDA). Benefit-risk assessment in drug regulatory decision-making Draft PDUFA VI Implementation Plan (FY2018-2022) 2018. URL: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/ https:\/\/www.fda.gov\/files\/about Benefit-Risk-Assessment-in-Drug-Regulatory-Decision-Making.pdf. Accessed: 2023-08-30."},{"key":"3805_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/10543406.2023.2170396","volume":"33","author":"X Ren","year":"2023","unstructured":"Ren X, Chen X, Wang W, Seifu Y. Estimand in benefit-risk assessment. J Biopharm Stat. 2023;33:452\u201365.","journal-title":"J Biopharm Stat"},{"key":"3805_CR22","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1016\/j.csda.2008.04.006","volume":"52","author":"A Bathke","year":"2008","unstructured":"Bathke A, Harrar S, Madden L. How to compare small multivariate samples using nonparametric tests. Comput Stat Data Anal. 2008;52:4951\u201365.","journal-title":"Comput Stat Data Anal"},{"key":"3805_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i04","volume":"76","author":"W Burchett","year":"2017","unstructured":"Burchett W, Ellis A, Harrar S, Bathke A. Nonparametric inference for multivariate data: the r package npmv. J Stat Softw. 2017;76:1\u201318.","journal-title":"J Stat Softw"},{"key":"3805_CR24","first-page":"149","volume":"6","author":"S Iddi","year":"2013","unstructured":"Iddi S, Molenberghs G. A marginalized model for zero-inflated, overdispersed and correlated count data. Electron J Appl Stat Anal. 2013;6:149\u201365.","journal-title":"Electron J Appl Stat Anal."},{"key":"3805_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/10543406.2015.1052487","volume":"26","author":"A Ivanova","year":"2016","unstructured":"Ivanova A, Molenberghs G, Verbeke G. Mixed model approaches for joint modeling of different types of responses. J Biopharm Stat. 2016;26:601\u201318.","journal-title":"J Biopharm Stat"},{"key":"3805_CR26","volume-title":"Models for Discrete Longitudinal Data","author":"G Molenberghs","year":"2005","unstructured":"Molenberghs G, Verbeke G. Models for Discrete Longitudinal Data. New York: Springer; 2005."},{"key":"3805_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1541-0420.2006.00507.x","volume":"62","author":"S Fieuws","year":"2006","unstructured":"Fieuws S, Verbeke G. Pairwise fitting of mixed models for the joint modeling of multivariate longitudinal profiles. Biometrics. 2006;62:424\u201331.","journal-title":"Biometrics"},{"key":"3805_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/psp4.12280","volume":"7","author":"S Ueckert","year":"2018","unstructured":"Ueckert S. Modeling composite assessment data using item response theory. CPT Pharmacometrics Syst Pharmacol. 2018;7:205\u201318. https:\/\/doi.org\/10.1002\/psp4.12280.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"3805_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2307\/2531158","volume":"40","author":"P O\u2019Brien","year":"1984","unstructured":"O\u2019Brien P. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;40:1079\u201387.","journal-title":"Biometrics"},{"key":"3805_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2307\/2533057","volume":"52","author":"J L\u00e4uter","year":"1996","unstructured":"L\u00e4uter J. Exact t and F tests for analyzing studies with multiple endpoints. Biometrics. 1996;52:964\u201370.","journal-title":"Biometrics"},{"key":"3805_CR31","doi-asserted-by":"crossref","unstructured":"Friedrich S, Konietschke F, Pauly M. Analysis of multivariate data and repeated measures designs with the R package MANOVA. RM. arXiv preprint arXiv:1801.08002. 2018","DOI":"10.32614\/RJ-2019-051"},{"key":"3805_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10543406.2018.1489402","volume":"29","author":"R Ristl","year":"2018","unstructured":"Ristl R, Urach S, Rosenkranz G, Posch M. Methods for the analysis of multiple endpoints in small populations: a review. J Biopharm Stat. 2018;29:1\u201329.","journal-title":"J Biopharm Stat"},{"key":"3805_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/9780470510445","volume-title":"Missing Data in Clinical Studies","author":"G Molenberghs","year":"2007","unstructured":"Molenberghs G, Kenward M. Missing Data in Clinical Studies. New York: John Wiley & Sons; 2007."},{"key":"3805_CR34","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.csda.2007.04.020","volume":"52","author":"C Beunckens","year":"2008","unstructured":"Beunckens C, Sotto C, Molenberghs G. A simulation study comparing weighted estimating equations with multiple imputation based estimating equations for longitudinal binary data. Comput Stat Data Anal. 2008;52:1533\u201348.","journal-title":"Comput Stat Data Anal"},{"key":"3805_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/9781119756118","volume-title":"Multiple Imputation and its Application 2e","author":"JR Carpenter","year":"2023","unstructured":"Carpenter JR, Kenward MG, Bartlett JW, Morris TP, Quartagno M, Wood AM. Multiple Imputation and its Application 2e. Wiley; 2023."},{"key":"3805_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/10543406.2013.834911","volume":"23","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Roger JH, Kenward MG. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation. J Biopharm Stat. 2013;23:1352\u201371.","journal-title":"J Biopharm Stat"},{"key":"3805_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/sym14020244","volume":"14","author":"K Rubarth","year":"2022","unstructured":"Rubarth K, Sattler P, Zimmermann HG, Konietschke F. Estimation and testing of wilcoxon-mann-whitney effects in factorial clustered data designs. Symmetry. 2022;14:244.","journal-title":"Symmetry"},{"key":"3805_CR38","unstructured":"Deltuvaite-Thomas V. Statistical inference using generalised pairwise comparisons in the presence of censored or missing data. Phd Thesis UHasselt 2022"},{"key":"3805_CR39","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/10543406.2017.1397007","volume":"28","author":"G Dong","year":"2018","unstructured":"Dong G, Qiu J, Wang D, Vandemeulebroecke M. The stratified win ratio. J Biopharm Stat. 2018;28:778\u20139.","journal-title":"J Biopharm Stat"},{"key":"3805_CR40","volume-title":"A Nonparametric Alternative to Analysis of Covariance, 109\u2013120","author":"A Bathke","year":"2003","unstructured":"Bathke A, Brunner E. A Nonparametric Alternative to Analysis of Covariance, 109\u2013120. The Netherlands: Elsevier B.V. Amsterdam; 2003."},{"key":"3805_CR41","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1080\/03610926.2015.1014106","volume":"46","author":"C Fan","year":"2017","unstructured":"Fan C, Zhang D. Rank repeated measures analysis of covariance. Commun Stat - Theory Methods. 2017;46:1158\u201383.","journal-title":"Commun Stat - Theory Methods"},{"issue":"4","key":"3805_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1467-9868.2011.01020.x","volume":"74","author":"O Thas","year":"2012","unstructured":"Thas O, Neve JD, Clement L, Ottoy JP. Probabilistic Index Models. J Royal Stat Soc Ser B: Stat Methodol. 2012;74(4):623\u201371. https:\/\/doi.org\/10.1111\/j.1467-9868.2011.01020.x.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol."},{"key":"3805_CR43","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/biom.13382","volume":"77","author":"L Mao","year":"2021","unstructured":"Mao L, Wang T. A class of proportional win-fractions regression models for composite outcomes. Biometrics. 2021;77:1265\u201375.","journal-title":"Biometrics"},{"key":"3805_CR44","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2307\/2533433","volume":"50","author":"D Hedeker","year":"1994","unstructured":"Hedeker D, Gibbons R. A random-effects ordinal regression model for multilevel analysis. Biometrics. 1994;50:933\u201344.","journal-title":"Biometrics"},{"key":"3805_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1023\/A:1025701327672","volume":"25","author":"M Tod","year":"1997","unstructured":"Tod M, Rocchisani J. Comparison of ed, eid, and api criteria for the robust optimization of sampling times in pharmacokinetics. J Pharmacokinet Biopharm. 1997;25:515\u201337.","journal-title":"J Pharmacokinet Biopharm"},{"key":"3805_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10928-005-2102-z","volume":"32","author":"M Dodds","year":"2005","unstructured":"Dodds M, Hooker A, Vicini P. Robust population pharmacokinetic experiment design. J Pharmacokinet Pharmacodyn. 2005;32:33\u201364.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"3805_CR47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2307\/2983440","volume":"158","author":"C Chatfield","year":"1995","unstructured":"Chatfield C. Model uncertainty, data mining and statistical inference. J Royal Stat Soc Ser A: Stat Soc. 1995;158(3):419\u201344.","journal-title":"J Royal Stat Soc Ser A: Stat Soc."},{"key":"3805_CR48","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1541-0420.2005.00344.x","volume":"61","author":"F Bretz","year":"2005","unstructured":"Bretz F, Pinheiro J, Branson M. Combining multiple comparisons and modeling techniques in dose-response studies. Biometrics. 2005;61:738\u201348.","journal-title":"Biometrics"},{"key":"3805_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/clpt.2010.9","volume":"87","author":"S Zamuner","year":"2010","unstructured":"Zamuner S, et al. Adaptive-optimal design in pet occupancy studies. Clinical Pharmacol Therapeutics. 2010;87:563\u201371.","journal-title":"Clinical Pharmacol Therapeutics"},{"key":"3805_CR50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/bjd\/ljae200","volume":"191","author":"E Korte","year":"2024","unstructured":"Korte E, et al. Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. Br J Dermatol. 2024;191:463\u20135. https:\/\/doi.org\/10.1093\/bjd\/ljae200.","journal-title":"Br J Dermatol"},{"key":"3805_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/bjd\/ljad077","volume":"189","author":"E Korte","year":"2023","unstructured":"Korte E, et al. Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization. Br J Dermatol. 2023;189:80\u201390.","journal-title":"Br J Dermatol"},{"key":"3805_CR52","doi-asserted-by":"publisher","first-page":"S","DOI":"10.25251\/skin.2.supp.55","volume":"2","author":"JW Bauer","year":"2018","unstructured":"Bauer JW, et al. Use of an investigator\u2019s global assessment scale to evaluate disease severity in patients swith epidermolysis bullosa simplex. SKIN J Cutaneous Med. 2018;2:S. https:\/\/doi.org\/10.25251\/skin.2.supp.55.","journal-title":"SKIN J Cutaneous Med"},{"key":"3805_CR53","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1002\/sim.4279","volume":"30","author":"L Kennes","year":"2011","unstructured":"Kennes L, Cramer E, Hilgers R-D, Heussen N. The impact of selection bias on test decisions in randomized clinical trials. Statist Med. 2011;30:2573\u201381.","journal-title":"Statist Med."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03805-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03805-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03805-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:21:34Z","timestamp":1749108094000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03805-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3805"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03805-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no Conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}